Document:

Exhibit 10.1

 

TERMINATION AND WAIVER AGREEMENT

 

This Termination and Waiver Agreement (this “Agreement”) is dated as of November 5, 2014, by and among KYTHERA Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), KYTHERA Holdings Ltd., a company incorporated under the laws of Bermuda (“KHL”) (solely for purposes of Article II hereof), and Bayer Consumer Care AG, a company organized under the laws of Switzerland (“Bayer”).

 

RECITALS

 

A.                                    The Company and Bayer are party to that certain Registration Rights Agreement, dated March 7, 2014 (the “Registration Rights Agreement”), providing for certain registration rights relating to shares of common stock (the “Shares”) of the Company issued pursuant to that certain Securities Purchase Agreement, dated March 7, 2014, by and among the Company, KHL and Bayer (the “Securities Purchase Agreement”).

 

B.                                    The Company, KHL and Bayer, as applicable, wish to terminate the Registration Rights Agreement and permanently and irrevocably waive certain provisions of the Securities Purchase Agreement only to the extent expressly set forth in this Agreement.

 

C.                                    Section 6(f) of the Registration Rights Agreement provides that it may be amended or waived in a written instrument signed by the Company and the holder of a majority of then outstanding Registrable Securities (as defined therein).

 

D.                                    Section 6.4 of the Securities Purchase Agreement provides that it may be waived, modified, supplemented or amended in a written instrument signed by the Company, KHL and Bayer.

 

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company, KHL (solely for purposes of Article II hereof) and Bayer hereby agree as follows:

 

ARTICLE I.
 REGISTRATION RIGHTS AGREEMENT

 

1.1       Representations.  Bayer hereby represents to the Company that Bayer is the Holder (as defined in the Registration Rights Agreement) of all Registrable Securities (as defined therein) outstanding as of the date of this Agreement.

 

1.2       Termination.  The Company and Bayer hereby agree to terminate the Registration Rights Agreement in its entirety, and the Registration Rights Agreement is hereby terminated in its entirety, including but not limited to the covenants and rights provided for therein and the provisions that would otherwise survive termination pursuant to Section 6(g) thereof; provided, however, that obligations of the Company in Section 6(e) shall survive until (and including) March 31, 2015.

 

ARTICLE II.
 SECURITIES PURCHASE AGREEMENT

 

2.1       Waiver and Covenant.  The Company and KHL hereby agree to waive permanently and irrevocably Sections 4.1(d) and 4.1(e) of the Securities Purchase Agreement, and Sections 4.1(d) and 4.1(e) of the Securities Purchase Agreement are hereby permanently and irrevocably waived. Bayer hereby agrees to act in good faith in conducting any sales or other disposition of the Shares in an orderly manner reasonably intended to minimize disruption of the public trading of the Company’s common stock, including but not limited to consulting with the Company (directly and/or through Bayer’s designated broker, Morgan Stanley) with respect to its plan of distribution with respect to the Shares, with such consultation being deemed satisfied by providing the Company (including telephonically if conveyed to the Chief Executive Officer, Chief Financial Officer or General Counsel of the Company, at least one of whom the Company shall cause to be available reasonably promptly upon request for such a telephone call) with a general description of Bayer’s anticipated sales of the Shares, and the anticipated process with respect thereto, in advance of the initial sale being made, but not repeatedly thereafter so long as such sales are generally reasonably consistent with the process previously described to the Company.

 

 

2.2       Legend Removal.  Prior to March 31, 2015, following any sales in compliance with Rule 144 that are referred to Section 2.1 above, Bayer agrees to provide (directly or through Morgan Stanley) a customary Rule 144 representation letter to the Company, in substantially the form previously provided to the Company (the “Representation Letter”). Upon receipt of the completed Representation Letter, and following Rule 144 becoming available for the resale of the Shares at such time at which there remains a requirement for the Company to be in compliance with the current public information required under Rule 144 (the “Current Public Information Requirement”), the Company shall promptly cause its counsel to provide a legal opinion as may reasonably be required by the Company’s transfer agent and shall issue any other necessary instructions to the transfer agent providing for the removal of the legend set forth in Section 4.1(b) of the Securities Purchase Agreement from any legended Shares which have been sold by Bayer, and shall use reasonable efforts to cause its transfer agent to issue any such shares so sold without restrictive legends within not later than three (3) business days following the receipt of the completed Representation Letter by the Company. Following Rule 144 becoming available for the resale of the Shares at such time at which the Current Public Information Requirement no longer applies, the Company confirms that Section 4.1(c) of the Securities Purchase Agreement shall govern any subsequent legend removals, and agrees that upon receipt from Bayer (directly or through Morgan Stanley) of the final completed Representation Letter requesting the removal of all legends, the Company shall promptly cause its counsel to provide a legal opinion as may reasonably be required by the Company’s transfer agent and shall issue any other necessary instructions to the transfer agent providing for the removal of the legend set forth in Section 4.1(b) of the Securities Purchase Agreement from any remaining legended Shares held by Bayer. Thereafter, no further Representation Letters or other notifications of sales shall be required of Bayer.

 

2.3       Confirmation. Except as expressly provided pursuant hereto, the Securities Purchase Agreement shall remain unchanged and in full force and effect and is hereby ratified and confirmed in all respects.

 

ARTICLE III.
 MISCELLANEOUS

 

3.1       Governing Law.  This Agreement and all disputes arising out of or related to this Agreement or any breach hereof shall be governed by and construed under the laws of the State of New York, without giving effect to any choice of law principles that would require the application of the laws of a different jurisdiction.

 

3.2       Execution.  This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart.  In the event that any signature is delivered by facsimile transmission, or by e-mail delivery of a data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof.

 

2

 

3.3       Severability.  If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

3

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly authorized representatives as of the date first written above.

 

 

	
 
    	
KYTHERA   BIOPHARMACEUTICALS, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Keith Leonard
    
	
 
    	
Name:   Keith Leonard
    
	
 
    	
Title:   President and CEO
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
KYTHERA   HOLDINGS LTD.
    
	
 
    	
(solely   for purposes of Article II hereof)
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Keith Leonard
    
	
 
    	
Name:   Keith Leonard
    
	
 
    	
Title:   President and CEO
    

 

[Signature Page to Termination and Waiver Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly authorized representatives as of the date first written above.

 

	
 
    	
BAYER   CONSUMER CARE AG
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Ernst Coppens
    
	
 
    	
Name:   Ernst Coppens
    
	
 
    	
Title:   CFO
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/   Pascal Buergin
    
	
 
    	
Name:   Pascal Buergin
    
	
 
    	
Title:   Legal Counsel
    

 

 

[Signature Page to Termination and Waiver Agreement]Exhibit 4.1

 

VIRGINIA HERITAGE BANK

2006 STOCK OPTION PLAN

(as amended July 26, 2007)

 

ARTICLE I

Establishment, Purpose, and Duration

 

1.1                               Establishment of the Plan. Virginia Heritage Bank, a state banking association formed under the laws of the Commonwealth of Virginia (the “Company”), hereby establishes an incentive compensation plan for the Company and its Subsidiaries to be known as the “2006 Stock Option Plan”, as set forth in this document.  Unless otherwise defined herein, all capitalized terms shall have the meanings set forth in Section 2.1 herein.  The Plan permits the grant of Incentive Stock Options and Non-Qualified Stock Options to Employees, Non-Qualified Stock Options to Non-Employee Directors, and Seed Investor Options to Seed Investors.

 

The Plan was adopted by the Board of Directors of the Company on May 3, 2006, and shall become effective on June 15, 2006 (the “Effective Date”), subject to the approval by vote of shareholders of the Company in accordance with applicable laws.  Awards under the Plan may not be granted prior to the later of the Effective Date of the Plan or the date of shareholder approval of the Plan.

 

1.2                               Purpose of the Plan.  The purpose of the Plan is to promote the success of the Company and its Subsidiaries by providing incentives to Employees and Non-Employee Directors that will promote the identification of their personal interest with the long-term financial success of the Company and with growth in shareholder value.  The Plan is designed to provide flexibility to the Company and its Subsidiaries, in its ability to motivate, attract, and retain the services of Employees and Non-Employee Directors upon whose judgment, interest, and effort the successful conduct of its operation is largely dependent, and to recognize and reward Seed Investors who contributed organizational funds and/or services which were at risk of loss if the Company’s organization had not been successful, whether or not they intend to serve as officers or directors of the Company.

 

1.3                               Duration of the Plan.  The Plan shall commence on the Effective Date, as described in Section 1.1 herein, and shall remain in effect, subject to the right of the Board of Directors to terminate the Plan at any time pursuant to Article IX herein, until June 14, 2016, at which time it shall terminate except with respect to Awards made prior to, and outstanding on, that date which shall remain valid in accordance with their terms.

 

ARTICLE II

Definitions

 

2.1                               Definitions.  Except as otherwise defined in the Plan, the following terms shall have the meanings set forth below:

 

(a)                                 “Affiliate” and “Associate” shall have the respective meanings ascribed to such terms in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

(b)                                 “Agreement” means a written agreement implementing the grant of each Award signed by an authorized officer or director of the Company and by the Participant.

 

(c)                                  “Award” or “Grant” means, individually or collectively, a grant under the Plan of Incentive Stock Options, Non-Qualified Stock Options or Seed Investor Options.

 

 

(d)                                 “Award Date” or “Grant Date” means the date on which an Award is made by the Committee under the Plan.

 

(e)                                  “Beneficial Owner” shall have the meaning ascribed to such term in Rule 13d-3 under the Exchange Act.

 

(f)                                   “Board” or “Board of Directors” means the Board of Directors of the Company, unless otherwise indicated.

 

(g)                                  “Change in Control” shall be deemed to have occurred if the conditions set forth in any one of the following paragraphs shall have been satisfied:

 

(i)                                     any Person (other than the Company, any Subsidiary, a trustee or other fiduciary holding securities under any employee benefit plan of the Company, or its Subsidiaries), who or which, together with all Affiliates and Associates of such Person, is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing 20% or more of the combined voting power of the Company’s then outstanding securities; or

 

(ii)                                  if, at any time after the Effective Date, the composition of the Board of Directors of the Company shall change such that a majority of the Board of the Company shall no longer consist of Continuing Directors; or

 

(iii)                               if at any time, (A) the Company shall consolidate with, or merge with, any other Person and the Company shall not be the continuing or surviving corporation, (B) any Person shall consolidate with or merge with the Company, and the Company shall be the continuing or surviving corporation and, in connection therewith, all or part of the outstanding Stock shall be changed into or exchanged for stock or other securities of any other Person or cash or any other property, (C) the Company shall be a party to a statutory share exchange with any other Person after which the Company is a subsidiary of any other Person, or (D) the Company shall sell or otherwise transfer 50% or more of the assets or earning power of the Company and its Subsidiaries (taken as a whole) to any Person or Persons.

 

(h)                                 “Code” means the Internal Revenue Code of 1986, as amended from time to time.

 

(i)                                     “Committee” means the committee of the Board appointed to administer the Plan pursuant to Article III herein, all of the members of which shall be “non-employee directors” as defined in Rule 16b-3, as amended, under the Exchange Act, or any similar or successor rule, and “outside directors” within the meaning of Section 162(m)(4)(C)(i) of the Code. Unless otherwise determined by the Board, the Committee shall consist of compensation committee of the Board.

 

(j)                                    “Company” means Virginia Heritage Bank, or any successor thereto as provided in Article XII herein.

 

(k)                                 “Continuing Director” means an individual who was a member of the Board of Directors of the Company on the Effective Date or whose subsequent nomination for election or re-election to the Board of Directors of the Company was recommended or approved by the affirmative vote of two-thirds of the Continuing Directors then in office.

 

2

 

(l)                                     “Employee” means a current or prospective officer or other employee of the Company or its Subsidiaries (including any corporation, partnership, limited liability company or joint venture which becomes a Subsidiary after the adoption of the Plan by the Board).

 

(m)                             “Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

(n)                                 “Fair Market Value” of a Share means the mean between the high and low sales price of the Stock on the relevant date if it is a trading date, or if not, on the most recent date on which the Stock was traded prior to such date, as reported by NASDAQ National Market or Capital Market System, or if, in the opinion of the Committee, this method is inapplicable or inappropriate for any reason, the fair market value as determined pursuant to a reasonable method adopted by the Committee in good faith for such purpose.

 

(o)                                 “Incentive Stock Option” or “ISO” means an option to purchase Stock, granted under Article VI herein, which is designated as an incentive stock option and is intended to meet the requirements of Section 422 of the Code.

 

(p)                                 “Non-Employee Director” means an individual who is a member of the Board of the Company or a Subsidiary on the applicable Award Date and who is not an employee of the Company or a Subsidiary (including any corporation, partnership, limited liability company or joint venture which becomes a Subsidiary after the adoption of the Plan by the Board).

 

(q)                                 “Non-Qualified Stock Option” or “NQSO” means an option to purchase Stock, granted under Article VI herein, which is not intended to be an Incentive Stock Option.

 

(r)                                    “Option” means an Incentive Stock Option or a Non-Qualified Stock Option.

 

(s)                                   “Participant” means an Employee, Non-Employee Director or Seed Investor who is granted an Award under the Plan.

 

(t)                                    “Person” shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, including a “group” as defined in Section 13(d).

 

(u)                                 “Plan” means the Virginia Heritage Bank 2006 Stock Option Plan, as described and as hereafter from time to time amended.

 

(v)                                 “Seed Investor” means an individual who substantially contributed to the organization of the Company whether or not the individual intends to serve as an active officer or director, as determined by the Committee.

 

(w)                               “Seed Investor Option” means an option to purchase Stock awarded to Seed Investors pursuant to Article VII hereof.

 

(x)                                 “Seed Investor Option Grant” means a grant of Seed Investor Options.

 

(y)                                 “Seed Investor Option Price” means the exercise price for Seed Investor Options awarded.

 

3

 

(z)                                  “Stock” or “Shares” means the common stock of the Company.

 

(aa)                          “Subsidiary” means any subsidiary corporation of the Company within the meaning of Section 424(f) of the Code (“Section 424(f) Corporation”) and any partnership, limited liability company or joint venture in which either the Company or a Section 424(f) Corporation is at least a fifty percent (50%) equity participant.

 

ARTICLE III

Administration

 

3.1                               The Committee.  The Plan shall be administered by the Committee, which shall have all powers necessary or desirable for such administration.  The express grant in the Plan of any specific power to the Committee shall not be construed as limiting any power or authority of the Committee.  In addition to any other powers and subject to the provisions of the Plan, the Committee shall have the following specific powers:  (i) to determine the terms and conditions upon which the Awards may be made and exercised; (ii) to determine all terms and provisions of each Agreement, which need not be identical; (iii) to construe and interpret the Agreements and the Plan; (iv) to establish, amend, or waive rules or regulations for the Plan’s administration; (v) to accelerate the exercisability of any Award or the termination of any restrictions imposed under the Plan; and (vi) to make all other determinations and take all other actions necessary or advisable for the administration of the Plan.

 

The Chairman of the Committee and such other directors and officers of the Company as shall be designated by the Committee are hereby authorized to execute Agreements on behalf of the Company and to cause them to be delivered to the recipients of Awards.

 

For purposes of determining the applicability of Section 422 of the Code (relating to Incentive Stock Options), or in the event that the terms of any Award provide that it may be exercised only during employment or service or within a specified period of time after termination of employment or service, the Committee may decide to what extent leaves of absence for governmental or military service, illness, temporary disability, or other reasons shall not be deemed interruptions of employment or service or continuous employment or service.

 

Subject to limitations under applicable law, the Committee is authorized in its discretion to issue Awards and/or accept notices, elections, consents and/or other forms or communications by Participants by electronic or similar means, including, without limitation, transmissions through e-mail, voice mail, recorded messages on electronic telephone systems, and other permissible methods, on such basis and for such purposes as it determines from time to time.

 

A majority of the entire Committee shall constitute a quorum and the action of a majority of the members present at any meeting at which a quorum is present (in person or as otherwise permitted by applicable law), or acts approved in writing by a majority of the Committee without a meeting, shall be deemed the action of the Committee.

 

3.2                               Selection of Participants.  The Committee shall have the authority to grant Awards under the Plan, from time to time, to such Employees, Non-Employee Directors and/or Seed Investors as may be selected by it to be Participants.  Each Award shall be evidenced by an Agreement.

 

3.3                               Decisions Binding.  All determinations and decisions made by the Board or the Committee pursuant to the provisions of the Plan shall be final, conclusive, and binding.

 

4

 

3.4                               Requirements of Rule 16b-3.  Notwithstanding any other provision of the Plan, the Board or the Committee may impose such conditions on any Award, and amend the Plan in any such respects, as may be required to satisfy the requirements of Rule 16b-3, as amended (or any successor or similar rule), under the Exchange Act.

 

Any provision of the Plan to the contrary notwithstanding, and except to the extent that the Committee determines otherwise:  (i) transactions by and with respect to officers and directors of the Company who are subject to Section 16(b) of the Exchange Act (hereafter, “Section 16 Persons”) shall comply with any applicable conditions of Rule 16b-3; and (ii) every provision of the Plan shall be administered, interpreted, and construed to carry out the foregoing provisions of this sentence.

 

3.5                               Indemnification of the Committee.  In addition to such other rights of indemnification as they may have as directors or as members of the Committee, the members of the Committee shall be indemnified by the Company against reasonable expenses, including attorneys’ fees, actually and reasonably incurred in connection with the defense of any action, suit, or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan or any Award granted or made hereunder, and against all amounts reasonably paid by them in settlement thereof or paid by them in satisfaction of a judgment in any such action, suit, or proceeding, if such members acted in good faith and in a manner which they believed to be in, and not opposed to, the best interests of the Company and its Subsidiaries.

 

3.6                               Certain Determinations.  In connection with the Committee’s good faith determination of Fair Market Value as required herein, the Committee may, as guidance, take into consideration the book value of the Stock of the Company, the relationship between the traded price and book value of shares for financial institutions of similar size and similar operating results to the Company and its subsidiary bank, any reasonably recent trades of the Stock of the Company brought to the attention of the Committee and such additional relevant information as the Committee in its judgment deems necessary.  In its sole discretion, the Committee may, but is not obligated to, consult with and/or engage an investment banker or other appropriate advisor to advise the Committee in connection with its good faith determination of Fair Market Value herein.

 

ARTICLE IV

Stock Subject to the Plan

 

4.1                               Number of Shares.  Subject to adjustment as provided in Section 4.3 herein, the maximum aggregate number of Shares that may be issued pursuant to Awards made under the Plan shall not exceed 250,000, and the maximum number of Shares that may be issued pursuant to Awards of Seed Investor Options under the Plan shall not exceed 78,000.  Except as provided in Section 4.2 herein, only Shares actually issued in connection with the exercise of, or as other payment for, Awards under the Plan shall reduce the number of Shares available for future Awards under the Plan.

 

4.2                               Lapsed Awards or Forfeited Shares; Shares Used as Payment of Exercise Price or for Taxes.

 

4.2(a)                If any Award granted under the Plan terminates, expires, or lapses for any reason other than by virtue of exercise of the Award, or if Shares issued pursuant to Awards are forfeited, any Stock subject to such Award again shall be available for the grant of an Award under the Plan.

 

4.2(b)                In the event a Participant pays the Option Price for Shares pursuant to the exercise of an Option with previously acquired Shares, the number of Shares available for future Awards under the Plan 

 

5

 

shall be reduced only by the net number of new Shares issued upon the exercise of the Option.  In addition, in determining the number of shares of Stock available for Awards, if Stock has been delivered or exchanged by, or withheld from, a Participant as full or partial payment to the Company for payment of withholding taxes, or if the number of shares of Stock otherwise deliverable by the Company has been reduced for payment of withholding taxes, the number of shares of Stock exchanged by or withheld from a Participant as payment in connection with the withholding tax or so reduced by the Company shall again be available for the grant of an Award under the Plan.

 

4.3                               Capital Adjustments.  The number and class of Shares subject to each outstanding Award, the Option Price or Seed Investor Option Price, as the case may be, and the annual limits on and the aggregate number and class of Shares for which Awards thereafter may be made shall be proportionately, equitably and appropriately adjusted in such manner as the Committee shall determine in order to retain the economic value or opportunity to reflect any stock dividend, stock split, recapitalization, merger, consolidation, reorganization, reclassification, combination, exchange of shares or similar event in which the number or class of Shares is changed without the receipt or payment of consideration by the Company.  Where an Award being adjusted is an ISO or is subject to Section 409A of the Code, the adjustment shall also be effected so as to comply with Section 424(a) of the Code and not to constitute a modification within the meaning of Section 424(h) or 409A, as applicable, of the Code.

 

ARTICLE V

Eligibility

 

Persons eligible to participate in the Plan and receive Awards are all Employees, all Non-Employee Directors and all Seed Investors who, in the opinion of the Committee, merit becoming Participants.

 

ARTICLE VI

Stock Options

 

6.1                               Grant of Options.  Subject to the terms and provisions of the Plan, Options may be granted to Employees and Non-Employee Directors at any time and from time to time as shall be determined by the Committee.  The Committee shall have complete discretion in determining the number of Shares subject to Options granted to each Participant, provided, however, that (i) no Participant may be granted Options in any calendar year for more than 25,000 Shares, (ii) the aggregate Fair Market Value (determined at the time the Award is made) of Shares with respect to which any Participant may first exercise ISOs granted under the Plan during any calendar year may not exceed $100,000 or such amount as shall be specified in Section 422 of the Code and rules and regulations thereunder, (iii) no ISO may be granted on or following the tenth anniversary of the earlier of the Effective Date of the Plan or the date of shareholder approval of the Plan, and (iv) no ISO may be granted to a Non-Employee Director.

 

6.2                               Option Agreement.  Each Option grant shall be evidenced by an Agreement that shall specify the type of Option granted, the Option Price (as defined in Section 6.3 herein), the duration of the Option, the number of Shares to which the Option pertains, any conditions imposed upon the exercisability of Options in the event of retirement, death, disability or other termination of employment or service, and such other provisions as the Committee shall determine.  The Agreement shall specify whether the Option is intended to be an Incentive Stock Option within the meaning of Section 422 of the Code, or a Non-Qualified Stock Option not intended to be an Incentive Stock Option within the meaning of Section 422 of the Code, provided, however, that if an Option is intended to be an Incentive Stock Option but fails to be such for any reason, it shall continue in full force and effect as a Non-Qualified Stock Option.

 

6

 

6.3                               Option Price.  The exercise price per Share of Stock covered by an Option (“Option Price”) shall be determined by the Committee subject to the following limitations.  The Option Price shall not be less than 100% of the Fair Market Value of such Stock on the Grant Date.  In addition, in order for an Option to be an ISO where an Option is granted to an Employee who, at the time of grant, owns (within the meaning of Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company, the Option must have an Option Price which is at least equal to 110% of the Fair Market Value of the Stock on the Grant Date.  In no event shall the Option Price be lower than 100% of the book value per Share as shown by the Company’s most recently published statement of its financial condition prior to such Grant Date.

 

6.4                               Duration of Options.  Each Option shall expire at such time as the Committee shall determine at the time of grant, provided, however, that no ISO shall be exercisable after the expiration of ten years from its Award Date.  In addition, in order for an Option to be an ISO where an Option is granted to an Employee who, at the time of grant, owns (within the meaning of Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company, the Option must not be exercisable after the expiration of five years from its Award Date.

 

6.5                               Exercisability.  Options granted under the Plan shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall determine, which need not be the same for all Participants.

 

6.6                               Method of Exercise.  Options shall be exercised by the delivery of a written notice to the Company in the form prescribed by the Committee setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full payment for the Shares.  The Option Price shall be payable to the Company in full either in cash, by delivery of Shares of Stock valued at Fair Market Value at the time of exercise, by delivery of a promissory note (in the Committee’s discretion and subject to restrictions and prohibitions of applicable law) or by a combination of the foregoing.

 

To the extent permitted under the applicable laws and regulations, at the request of the Participant and with the consent of the Committee, the Company agrees to cooperate in a “cashless exercise” of an Option.  The cashless exercise shall be effected by the Participant delivering to a securities broker instructions to exercise all or part of the Option, including instructions to sell a sufficient number of shares of Stock to cover the costs and expenses associated therewith.

 

As soon as practicable, after receipt of written notice and payment of the Option Price and completion of payment of (or an arrangement satisfactory to the Company for the Participant to pay) any tax withholding required in connection with the Option exercise, the Company shall cause the appropriate number of Shares to be issued in the Participant’s name, which issuance shall be effected in book entry or electronic form, provided that issuance and delivery in certificated form shall occur if the Participant so requests or the Committee so directs.

 

6.7                               Restrictions on Stock Transferability.  The Committee shall impose such restrictions on any Shares acquired pursuant to the exercise of an Option under the Plan as it may deem advisable, including, without limitation, restrictions under applicable Federal securities law, under any stock exchange upon which such Shares are then listed and under any blue sky or state securities laws applicable to such Shares. In the event the Committee so provides in an Agreement pertaining to an Option, Stock delivered on exercise of the Option may be designated as restricted stock or Stock subject to a buyback right by the Company in the amount of, or based on, the Option Price therefor or otherwise in the event the Participant does not complete a specified service period after exercise.

 

7

 

 

ARTICLE VII

Seed Investor Options

 

7.1                               Grant of Seed Investor Options.  Subject to the terms and provisions of the Plan, Seed Investor Options may be granted to Seed Investors at any time during the first year after the Effective Date as determined by the Committee.  The Committee shall have complete discretion of determining the number of Shares subject to Seed Investor Options granted to each Seed Investor; provided, however, that (i) no Seed Investor may be granted an aggregate amount of Seed Investor Options for more than that number of Shares resulting from dividing the amount of funds placed at risk by the Seed Investor to facilitate the organization of the Company by $10.00, (ii) Seed Investor Options may be granted in addition to any other Option or Award granted hereunder, and (iii) Seed Investor Options may be granted only to organizers who placed at-risk funds to include seed money actually paid into the organizational fund for the formation of the Company and/or the market value of legal, accounting, or other professional services rendered.

 

7. 2                            Seed Investor Option Agreement.  Each Seed Investor Option Grant shall be evidenced by an agreement that shall specify the Seed Investor Option Price (as defined in Section 7.3), the duration of the Seed Investor Option, the number of Shares to which the Seed Investor Option pertains, any conditions imposed upon the exercisability of the Seed Investor Options in the event of death, and such other provisions as the Committee shall determine.

 

7. 3                            Seed Investor Option Price.  The exercise price per Share of Stock covered by a Seed Investor Option (“Seed Investor Option Price”) shall be equal to the greater of (i) the Fair Market Value of such Stock on the Grant Date as determined by the Committee or (ii) the book value per Share as shown by the Company’s most recently published statement of its financial condition prior to the Grant Date of such Seed Investor Option.

 

7.4                               Duration of Seed Investor Options.  Each Seed Investor Option shall expire at such time as the Committee shall determine at the time of Seed Investor Option Grant, provided, however, that no Seed Investor Option shall be exercised after the expiration of 10 years from its Award Date.

 

7.5                               Exercisability.  Seed Investor Options granted under the Plan shall be subject to such restrictions and conditions as the Committee shall determine, which need not be the same for all Seed Investors, provided that each Seed Investor Option will be immediately exercisable on its Grant Date.

 

7.6                               Method of Exercise.  Seed Investor Options shall be exercised by the delivery of a written notice to the Company in a form prescribed by the Committee setting forth the number of Shares with respect to which the Seed Investor Option is to be exercised, accompanied by full payment for the Shares.  The Seed Investor Option Price shall be payable to the Company in full in cash.  Cashless exercises of Seed Investor Options are not permissible.  As soon as practicable, after receipt of written notice and payment of the Seed Investor Option Price and completion of the payment of any tax withholding required in connection the Seed Investor Option exercise, the Company shall cause the appropriate number of Shares to be issued in the Seed Investor’s name, which issuance shall be effected in book entry or electronic form, provided the issuance and delivery in certificated form shall occur if the Seed Investor so requests or the Committee so directs.

 

7.7                               Severability.  The Committee may, in its discretion and without shareholder approval, sever the terms of the Plan as they pertain to Seed Investor Options from the remaining portions of the Plan and in doing so may create two separate plans, incorporating into the Seed Investor Stock Option 

 

8

 

Plan such provisions of the 2006 Stock Option Plan as are necessary to make both plans function independently.

 

ARTICLE VIII

Change in Control

 

In the event of a Change in Control of the Company, the Committee, as constituted before such Change in Control, in its sole discretion may, as to any outstanding Award, either at the time the Award is made or any time thereafter, take any one or more of the following actions: (i) provide for the acceleration of any time periods relating to the exercise or realization of any such Award so that such Award may be exercised or realized in full on or before a date initially fixed by the Committee; (ii) provide for the purchase or settlement of any such Award by the Company, with or without a Participant’s request, for an amount of cash equal to the amount which could have been obtained upon the exercise of such Award or realization of such Participant’s rights had such Award been currently exercisable or payable; (iii) make such adjustment to any such Award then outstanding as the Committee deems appropriate to reflect such Change in Control; or (iv) cause any such Award then outstanding to be assumed, or new rights substituted therefor, by the acquiring or surviving corporation in such Change in Control.

 

ARTICLE IX

Modification, Extension and Renewals of Awards

 

Subject to the terms and conditions and within the limitations of the Plan, the Committee may modify, extend or renew outstanding Awards and may modify the terms of an outstanding Agreement, provided that the exercise price of any Award may not be lowered other than pursuant to Section 4.3 herein. In addition, the Committee may accept the surrender of outstanding Awards granted under the Plan or outstanding awards granted under any other equity compensation plan of the Company and authorize the granting of new Awards pursuant to the Plan in substitution therefor so long as the new or substituted awards do not specify a lower exercise price than the surrendered Awards or awards, and otherwise the new Awards may be of a different type than the surrendered Awards or awards, may specify a longer term than the surrendered Awards or awards, may provide for more rapid vesting and exercisability than the surrendered Awards or awards, and may contain any other provisions that are authorized by the Plan. Notwithstanding the foregoing, however, no modification of an Award shall, without the consent of the Participant, adversely affect the rights or obligations of the Participant.

 

ARTICLE X

Amendment, Modification and Termination of the Plan

 

10.1                        Amendment, Modification and Termination.  At any time and from time to time, the Board may terminate, amend, or modify the Plan.  Such amendment or modification may be without shareholder approval except to the extent that such approval is required by the Code, pursuant to the rules under Section 16 of the Exchange Act, by any national securities exchange or system on which the Stock is then listed or reported, by any regulatory body having jurisdiction with respect thereto or under any other applicable laws, rules or regulations.

 

10.2                        Awards Previously Granted.  No termination, amendment or modification of the Plan other than pursuant to Section 4.3 herein shall in any manner adversely affect any Award theretofore granted under the Plan, without the written consent of the Participant.

 

9

 

ARTICLE XI

Withholding

 

11.1                        Tax Withholding.  The Company shall have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy Federal, State and local taxes (including the Participant’s FICA obligation, if any) required by law to be withheld with respect to any grant, exercise, or payment made under or as a result of the Plan.

 

11.2                        Stock Withholding.  With respect to withholding required upon the exercise of Non-Qualified Stock Options, or upon the lapse of restrictions, or upon the occurrence of any other taxable event with respect to any Award, Participants may elect, subject to the approval of the Committee, or the Committee may require Participants to satisfy the withholding requirement, in whole or in part, by having the Company withhold Shares of Stock having a Fair Market Value equal to the amount required to be withheld.  The value of the Shares to be withheld shall be based on the Fair Market Value of the Shares on the date that the amount of tax to be withheld is to be determined.  All elections by Participants shall be irrevocable and be made in writing and in such manner as determined by the Committee in advance of the day that the transaction becomes taxable.

 

ARTICLE XII

Successors

 

All obligations of the Company under the Plan, with respect to Awards granted hereunder, shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation or otherwise, of all or substantially all of the business and/or assets of the Company.

 

ARTICLE XIII

General

 

13.1                        Requirements of Law.  The granting of Awards and the issuance of Shares of Stock under the Plan shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or self-regulatory organizations (i.e., exchanges) as may be required.

 

13.2                        Effect of Plan.  The establishment of the Plan shall not confer upon any Employee, Non-Employee Director or Seed Investor any legal or equitable right against the Company, a Subsidiary or the Committee, except as expressly provided in the Plan. The Plan does not constitute an inducement or consideration for the employment or service of any Employee, Non-Employee Director or Seed Investor, nor is it a contract between the Company or any of its Subsidiaries and any Employee, Non-Employee Director or Seed Investor.  Participation in the Plan shall not give any Employee, Non-Employee Director or Seed Investor any right to be retained in the employment or service of the Company or any of its Subsidiaries.  Except as may be otherwise expressly provided in the Plan or in an Agreement, no Employee, Non-Employee Director or Seed Investor who receives an Award shall have rights as a shareholder of the Company prior to the date Shares are issued to the Participant pursuant to the Plan.

 

13.3                        Creditors.  The interests of any Participant under the Plan or any Agreement are not subject to the claims of creditors and may not, in any way, be assigned, alienated or encumbered.

 

13.4                        Governing Law.  The Plan, and all Agreements hereunder, shall be governed, construed and administered in accordance with the laws of the Commonwealth of Virginia and the intention of the Company is that ISOs granted under the Plan qualify as such under Section 422 of the Code.

 

10

 

13.5                        Severability.  In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.

 

13.6                        Unfunded Status of Plan.  The Plan is intended to constitute an “unfunded” plan for incentive and deferred compensation. With respect to any payments as to which a Participant has a fixed and vested interest but which are not yet made to a Participant by the Company, nothing contained herein shall give any such Participant any rights that are greater than those of a general unsecured creditor of the Company.

 

13.7                        Transferability.  Unless the Agreement evidencing an Award (or an amendment thereto authorized by the Committee) expressly states that it is transferable as provided in this section, no Award granted under the Plan, nor any interest in such Award, may be sold, assigned, conveyed, gifted, pledged, hypothecated or otherwise transferred in any manner, other than by will or the laws of descent and distribution, prior to the vesting or lapse of any and all restrictions applicable to any Shares issued under an Award. The Committee may in its sole discretion grant an Award (other than an ISO) or amend an outstanding Award (other than an ISO) to provide that the Award is transferable or assignable to a member or members of the Participant’s “immediate family,” as such term is defined under Exchange Act Rule 16a-l(e), or to a trust for the benefit solely of a member or members of the Participant’s immediate family, or to a partnership or other entity whose only owners are members of the Participant’s family, provided that following any such transfer or assignment the Award will remain subject to substantially the same terms applicable to the Award while held by the Participant, as modified as the Committee in its sole discretion shall determine appropriate, and the Participant shall execute an agreement agreeing to be bound by such terms.

 

13.8                        Termination of Employment or Service.  Except in the case of Seed Investor Options, unless otherwise provided in the Agreement pertaining to an Award, in the event that a Participant terminates his employment or service with the Company and its Subsidiaries for any reason, then the unvested portion of such Award shall automatically be forfeited to the Company. Unless otherwise provided in the Agreement pertaining to an Award, in determining cessation of employment or service, transfers between the Company and/or any Subsidiary shall be disregarded, and changes in status between that of an Employee and a Non-Employee Director shall be disregarded. The Committee may provide in an Agreement made under the Plan for vesting of Awards in connection with the termination of a Participant’s employment or service on such basis as it deems appropriate, including, without limitation, any provisions for vesting at death, disability, retirement or in connection with a Change in Control with or without the further consent of the Committee. The Agreements evidencing Awards may contain such provisions as the Committee may approve with reference to the effect of approved leaves of absence.

 

13.9                        Registration and Other Laws And Regulations.  The Plan, the grant and exercise of Awards hereunder, and the obligation of the Company to sell, issue or deliver Shares under such Awards, shall be subject to all applicable federal, state and foreign laws, rules and regulations and to such approvals by any governmental or regulatory agency as may be required. The Company shall not be required to register in a Participant’s name or deliver any Shares prior to the completion of any registration or qualification of such Shares under any federal, state or foreign law or any ruling or regulation of any government body which the Committee shall, in its sole discretion, determine to be necessary or advisable.

 

11

 

13.10                 Banking Regulatory Provision.  All Awards under the Plan are subject to a direction by the Company’s primary federal banking regulator which requires Participants to exercise or forfeit the stock rights contained in their Awards if the Company’s capital falls below the minimum requirements, as determined by the Company’s state or primary federal banking regulator.  In addition, all Awards shall be subject to any other conditions, limitations and prohibitions under any other financial institution regulatory policy or rule to which the Company is subject.

 

13.11                 Nonqualified Deferred Compensation Plan Omnibus Provision.  It is intended that any compensation, benefits or other remuneration which is provided pursuant to or in connection with the Plan which is considered to be nonqualified deferred compensation subject to Section 409A of the Code shall be provided and paid in a manner, and at such time and in such form, as complies with the applicable requirements of Section 409A of the Code to avoid the unfavorable tax consequences provided therein for non-compliance. The Committee is authorized to amend any Agreement and to amend or declare void any election by a Participant as may be determined by it to be necessary or appropriate to evidence or further evidence required compliance with Section 409A of the Code.

 

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]